KAMADA LTDNARY SHARES
KAMADA LTDNARY SHARES
Share · IL0010941198 · KMDA (XNAS)
Overview Financial Indicators
6,60 USD
-1,87 % -0,13 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 21:30

Current Prices from KAMADA LTDNARY SHARES

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
KMDA
USD
06.06.2025 21:30
6,60 USD
6,77 USD
-2,45 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -3,16 % -0,91 % -8,78 % 8,62 % 27,99 % -17,24 %

Company Profile for KAMADA LTDNARY SHARES Share

Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis ; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.

Invested Funds

The following funds have invested in: KAMADA LTDNARY SHARES invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
7,70
Percentage (%)
0,02 %

Company Data

Name KAMADA LTDNARY SHARES
Company Kamada Ltd.
Symbol KMDA
Website https://www.kamada.com
Primary Exchange XNAS NASDAQ
ISIN IL0010941198
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Amir London
Market Capitalization 376 Mio
Country Israel
Currency USD
Employees 0,4 T
Address 2 Holzman Street, 7670402 Rehovot
IPO Date 2013-05-31

Ticker Symbols

Name Symbol
NASDAQ KMDA

More Shares

Investors who KAMADA LTDNARY SHARES hold also have the following shares in their portfolio:
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMGEN INC
AMGEN INC Share
AUTODESK INC
AUTODESK INC Share
CINTAS CORP
CINTAS CORP Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
D/B/A CENTERSPACE
D/B/A CENTERSPACE Share
INTEL CORP
INTEL CORP Share
INTERNATIONAL FINANCE CORPORATION CALL ZRO CPN NTS 29/11/46
INTERNATIONAL FINANCE CORPORATION CALL ZRO CPN NTS 29/11/46 Bond
J2 GLOBAL INC
J2 GLOBAL INC Share
MICROSOFT CORP
MICROSOFT CORP Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
VALARIS 18/26
VALARIS 18/26 Bond
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025